Skip to main content

Month: July 2023

Vertex to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

KING OF PRUSSIA, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release second quarter 2023 financial results before the market opens on Wednesday, August 9, 2023. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day. Those wishing to participate may do so by dialing 1-201-689-8471 approximately ten minutes prior to start time. A listen-only webcast of the call will also be available through the Company’s Investor Relations website at https://ir.vertexinc.com. A conference call replay will be available approximately one hour after the call by dialing 1-412-317-6671 and referencing passcode 13739853, or via the Company’s Investor Relations website. The replay will expire on August...

Continue reading

Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants

Tel Aviv, Israel / Vancouver, Canada, July 17, 2023 (GLOBE NEWSWIRE) —  Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has issued 17,899 common shares in the capital of the Company (“Shares”) in lieu of the final payment of $10,000, starting May 1st 2022, to consultants of the Company. In addition, the Company has issued restricted stock units (“RSUS”) for additional consultant in lieu of payment of $5,000. All Shares will only be subjected to those restrictions designated in applicable securities laws. About Clearmind Medicine Inc. Clearmind is a psychedelic pharmaceutical biotech company...

Continue reading

CrossAmerica Partners to Announce Second Quarter 2023 Earnings Results on August 7

Allentown, PA, July 17, 2023 (GLOBE NEWSWIRE) — CrossAmerica Partners to Announce Second Quarter 2023 Earnings Results on August 7 ALLENTOWN, PA, July 17, 2023 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its second quarter 2023 results after the market closes on Monday, August 7, 2023. In conjunction with the news release, management will host a conference call on Tuesday, August 8 at 9:00 a.m. Eastern Time. The conference call numbers are 888-396-8049 or 416-764-8646 and the passcode for both is 70854269. A live audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section of the CrossAmerica website...

Continue reading

Berry Corporation Announces Acquisition of Macpherson Energy Corporation

Attractively Priced Acquisition of Oil Producing Assets Reflects Disciplined Capital Returns Strategy to Deliver Enhanced Free Cash Flow DALLAS, July 17, 2023 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced today that it has executed a definitive agreement to acquire Macpherson Energy Corporation, a privately held Kern County, California operator, for $70 million in cash, subject to customary purchase price adjustments. The transaction is structured such that $50 million will be paid at closing and the remainder paid in July 2024. This is a value creating transaction for Berry and our shareholders that we expect to be fully paid for by mid-year 2024 based on current projections for the pro forma company and $75/barrel Brent pricing. Substantially all of the purchase price will come...

Continue reading

Royalty Pharma Declares Third Quarter 2023 Dividend

NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2023 of $0.20 per Class A ordinary share. The dividend will be paid on September 15, 2023, to shareholders of record at the close of business on August 18, 2023. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Continue reading

CrossFirst Bankshares, Inc. Reports Second Quarter 2023 Results

LEAWOOD, Kan., July 17, 2023 (GLOBE NEWSWIRE) — CrossFirst Bankshares, Inc. (Nasdaq: CFB), the bank holding company for CrossFirst Bank, today reported operating results for the second quarter ended June 30, 2023. The second quarter earnings release can be viewed here: https://investors.crossfirstbankshares.com/financials/quarterly-reports CrossFirst Bankshares, Inc. will host a conference call to review second quarter results on Tuesday, July 18, 2023, at 10 a.m. CT / 11 a.m. ET. To access the event by telephone, please dial (844) 481-2831 at least fifteen minutes prior to the start of the call and request access to the CrossFirst Bankshares call. International callers should dial +1 (412) 317-1851 and request access as directed above. The event will also be broadcast live over the internet and can be accessed via the following...

Continue reading

PrairieSky Announces 2023 Second Quarter Results, Including Record Oil Royalty Production

CALGARY, Alberta, July 17, 2023 (GLOBE NEWSWIRE) — PrairieSky Royalty Ltd. (“PrairieSky” or the “Company“) (TSX: PSK) is pleased to announce its second quarter (“Q2 2023“) results for the three-month period ended June 30, 2023. Second Quarter Highlights:Record quarterly average oil royalty production of 12,607 barrels per day, a 3% increase over Q1 2023 and Q2 2022 with total royalty production averaging 23,517 BOE per day. Revenues totaled $117.4 million, 7% lower than Q1 2023 and 41% below Q2 2022, comprised of royalty production revenues of $108.4 million and other revenues of $9.0 million. Quarterly funds from operations of $91.3 million ($0.38 per common share, basic and diluted) were driven by oil royalty production growth and were 6% above Q1 2023 and 43% below Q2 2022. Declared a second...

Continue reading

Northann Corp. Appoints David M. Kratochvil as Chief Financial Officer

NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) — Northann Corp., a technology innovator, producer of natural and sustainable material-based products for interior finishes, today announced the appointment of David M. Kratochvil as its new Chief Financial Officer, effective July 14, 2023. Kratochvil brings more than 25 years of international, transactional, and Wall Street experience to the Northann Corp. team. With an extensive background in strategic and operational finance, coupled with significant capital markets knowledge, he will be integral as the company continues its journey in advancing innovation and sustainability. “We are thrilled to have David join our team. His blend of financial acumen, strategic insight, and executive leadership will help drive Northann’s development, revenue growth, and will help build our team as we...

Continue reading

Baltic Horizon Fund publishes its NAV for June 2023

The net asset value (NAV) of the Baltic Horizon Fund (the Fund) unit at the end of June 2023 amounted to EUR 0.9905 per unit. Compared to the previous month, NAV per unit decreased by 10.4%. The total net asset value of the Fund amounted to EUR 118.5 million over the month. The NAV decrease was mainly affected by the mid-year revaluation of investment properties. The EPRA NRV as of 30 June 2023 was EUR 1.0208 per unit, corresponding to a decrease of 11.8% over the last month. At the end of June 2023, new portfolio valuations were conducted by an independent real estate appraiser Colliers. As of 30 June 2023, the fair value of the Baltic Horizon Fund portfolio decreased to EUR 255.7 million (like-for-like portfolio as of 31 December 2022: 268.9 million). Compared to the previous valuations, the change in portfolio value was mainly driven...

Continue reading

Baltic Horizon Fund publishes its NAV for June 2023

The net asset value (NAV) of the Baltic Horizon Fund (the Fund) unit at the end of June 2023 amounted to EUR 0.9905 per unit. Compared to the previous month, NAV per unit decreased by 10.4%. The total net asset value of the Fund amounted to EUR 118.5 million over the month. The NAV decrease was mainly affected by the mid-year revaluation of investment properties. The EPRA NRV as of 30 June 2023 was EUR 1.0208 per unit, corresponding to a decrease of 11.8% over the last month. At the end of June 2023, new portfolio valuations were conducted by an independent real estate appraiser Colliers. As of 30 June 2023, the fair value of the Baltic Horizon Fund portfolio decreased to EUR 255.7 million (like-for-like portfolio as of 31 December 2022: 268.9 million). Compared to the previous valuations, the change in portfolio value was mainly driven...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.